This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Prospective, open-label, non-controlled, multicent...
Clinical trial

Prospective, open-label, non-controlled, multicenter, phase III clinical study to evaluate the efficacy and safety of octagam 10% in primary immune thrombocytopenia

Read time: 1 mins
Last updated:4th Apr 2012
To assess the efficacy of Octagam 10% in correcting the platelet count (PC).
Category Value
Study start date 2012-04-04

View full details